Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism
about
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosisHuman piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor geneEpidermolysis bullosa simplex: a keratin 5 mutation is a fully dominant allele in epidermal cytoskeleton functionInvestigation of KIT gene mutations in women with 46,XX spontaneous premature ovarian failureSingle missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2BMouse homologues of human hereditary disease.KIT is required for hepatic function during mouse post-natal development.Chromosome 13q deletion with Waardenburg syndrome: further evidence for a gene involved in neural crest function on 13q.Interstitial deletion of bands 4q12-->q13.1: case report and review of proximal 4q deletions.The KIT gene is associated with the english spotting coat color locus and congenital megacolon in Checkered Giant rabbits (Oryctolagus cuniculus).Mutations of the KIT (mast/stem cell growth factor receptor) proto-oncogene account for a continuous range of phenotypes in human piebaldism.Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldismKIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in mice.Human neural crest stem cells derived from human ESCs and induced pluripotent stem cells: induction, maintenance, and differentiation into functional schwann cells.Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.Biphasic expression of two paracrine melanogenic cytokines, stem cell factor and endothelin-1, in ultraviolet B-induced human melanogenesis.Increased Kit/SCF receptor induced mitogenicity but abolished cell motility after inhibition of protein kinase C.Effect of the c-kit codon 584 Phe----Leu substitution demonstrated in human piebaldism.Reply to Fleischman.
P2860
Q22001442-30A5F799-2831-4F22-829D-A5E3E0EDB30EQ24629192-EC2EBAB8-D5F9-40E1-AC70-A0BA340B3A17Q24673017-147AC6AF-AF20-4013-BB1E-2C2F31919C41Q24799860-877FC7E0-FE00-40E3-B8C8-C3E9C4B197BEQ28776010-0FFC22C6-187D-4251-B999-797F2F581CC9Q30495383-96A1C61F-EC6F-47E5-B3B8-01C5B2E2D6BDQ33289995-48CF15DC-B2AF-4539-9095-D9856B696D7DQ33677092-81F48C56-6D03-4E30-AAA3-74154723B177Q33679640-ABC63680-84E1-40CE-99FE-621360B5090AQ35149142-04575CFB-462D-4AD4-BC47-D579C2E85C68Q35196078-57A96C70-EFEC-4D6D-8F29-1ABFEC4642B1Q35643720-CF1671FC-4448-4384-83A3-7EDEB50BF78BQ35776437-1B48E2D0-0A83-4E7E-81C0-9B8B6BF99607Q36861526-14382D14-B77F-40AC-B478-80E0C2454A5EQ37748089-41A3FB48-8512-446E-B7B4-02E34C2BB6B4Q38784165-600B895B-5FC0-4912-A7C8-444E95615125Q40874259-7BB56499-8628-4A91-BBEF-BB438035F35DQ43146522-45ED27B6-73E7-4CB9-9A8A-2D1BCBFBBDF6Q46451412-5F8AD495-092E-4BA2-B698-E99AF83E8B7F
P2860
Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism
description
1992 nî lūn-bûn
@nan
1992 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Dominant negative and loss of ...... o-oncogene in human piebaldism
@ast
Dominant negative and loss of ...... o-oncogene in human piebaldism
@en
Dominant negative and loss of ...... o-oncogene in human piebaldism
@nl
type
label
Dominant negative and loss of ...... o-oncogene in human piebaldism
@ast
Dominant negative and loss of ...... o-oncogene in human piebaldism
@en
Dominant negative and loss of ...... o-oncogene in human piebaldism
@nl
prefLabel
Dominant negative and loss of ...... o-oncogene in human piebaldism
@ast
Dominant negative and loss of ...... o-oncogene in human piebaldism
@en
Dominant negative and loss of ...... o-oncogene in human piebaldism
@nl
P2093
P2860
P1476
Dominant negative and loss of ...... o-oncogene in human piebaldism
@en
P2093
L B Giebel
R A Spritz
S A Holmes
P2860
P407
P577
1992-02-01T00:00:00Z